5-hydroxypropafenone has been researched along with Arrhythmias, Cardiac in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belloni, M; Bernasconi, R; Cappiello, E; Castel, JM; Giani, P; Landolina, M; Latini, R; Leopaldi, D | 1 |
| Follath, F; Ha, HR; Oti-Amoako, K; Vozeh, S | 1 |
| Frey, B; Plass, H; Probst, P; Pürerfellner, H; Schmidinger, H; Steurer, G; Weber, H | 1 |
| Funck-Brentano, C; Kroemer, HK; Pavlou, H; Roden, DM; Woosley, RL | 1 |
| Brewington, J; Kirsten, EB; Zoble, RG | 1 |
| McAllister, CB; Roden, DM; Siddoway, LA; Thompson, KA; Wang, T; Wilkinson, GR; Woosley, RL | 1 |
| Kates, RE; Winkle, RA; Yee, YG | 1 |
1 trial(s) available for 5-hydroxypropafenone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Electrocardiography; Female; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Random Allocation | 1989 |
6 other study(ies) available for 5-hydroxypropafenone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Child; Debrisoquin; Female; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Propafenone | 1992 |
The relative potency of major metabolites and enantiomers of propafenone in an experimental reperfusion arrhythmia model.
Topics: Animals; Arrhythmias, Cardiac; Biotransformation; Chromatography, High Pressure Liquid; Male; Myocardial Reperfusion Injury; Propafenone; Rats; Rats, Inbred Strains; Stereoisomerism | 1990 |
Plasma propafenone concentration in the evaluation of anti-arrhythmic efficacy.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Propafenone; Ventricular Function, Left | 1991 |
Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.
Topics: Adult; Aged; Arrhythmias, Cardiac; Biotransformation; Electrocardiography; Female; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Propafenone; Quinidine | 1989 |
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cytochrome P-450 CYP2D6; Debrisoquin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; In Vitro Techniques; Kinetics; Liver; Male; Middle Aged; Mixed Function Oxygenases; Phenotype; Propafenone; Time Factors | 1987 |
Metabolite cumulation during chronic propafenone dosing in arrhythmia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Propafenone; Propiophenones; Time Factors | 1985 |